|
| ID |
DDInter737 |
| Drug Type |
small molecule |
| Molecular Formula |
C19H33No2 |
| Molecular Weight |
307.478
|
| Description |
Fingolimod is a sphingosine 1-phosphate receptor modulator used to treat patients with the relapsing-remitting form of multiple sclerosis (MS) and studied to manage lung complications of COVID-19.
|
| ATC Classification |
L04AA27
|
| IUPAC Name |
2-Amino-2-[2-(4-Octylphenyl)Ethyl]Propane-1,3-Diol |
| InChI |
Inchi=1S/C19H33No2/C1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)13-14-19(20,15-21)16-22/H9-12,21-22H,2-8,13-16,20H2,1H3 |
| InChI Key |
KKGQTZUTZRNORY-UHFFFAOYSA-N |
| Canonical SMILES |
CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1 |
| Useful Links |
DrugBank
ChEMBL
PubChem
|